The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis

por Ruiz-Padilla, A. J., Gamez-Nava, J. I., Saldaña-Cruz, A. M., Murillo-Vazquez, J. D., Vazquez-Villegas, M. L., Zavaleta-Muñiz, S. A., Martín-Márquez, B. T., Ponce-Guarneros, J. M., Rodriguez Jimenez, N. A., Flores-Chavez, A., Sandoval-Garcia, F., Vasquez-Jimenez, J. C., Cardona-Muñoz, E. G., Totsuka-Sutto, S. E., Gonzalez-Lopez, L.
Publicado 2016

Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cro...

por Nava-Valdivia, C. A., Ponce-Guarneros, J. M., Saldaña-Cruz, A. M., Corona-Sanchez, E. G., Ramirez-Villafaña, M., Perez-Guerrero, E. E., Murillo-Saich, J. D., Contreras-Haro, B., Vazquez-Villegas, M. L., Gonzalez-Ponce, F., Bonilla-Lara, D., Jacobo-Cuevas, H., Centeno-Valadez, J. D., Echeverria-Gonzalez, G., Cerpa-Cruz, S., Alcaraz-Lopez, M. F., Cardona-Muñoz, E. G., Salazar-Paramo, M., Gonzalez-Lopez, L., Gamez-Nava, J. I.
Publicado 2021